A Phase II randomised study investigating the efficacy of standard Or high-dose Ofatumumab in combination with chemotherapy in relapsed chronic lymphocytic leukaemia.
Allsup, D Howard, D Munir, T Hockaday, A Rawstron, A Collett, L McParland, L Oughton, J Bloor, Adrian Phillips, D
Allsup, D
Howard, D
Munir, T
Hockaday, A
Rawstron, A
Collett, L
McParland, L
Oughton, J
Bloor, Adrian
Phillips, D
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Summary of EGFR-Biomarker data from the randomized, controlled phase 3 trial SQUIRE on adding Necitumumab to first-line Gemcitabine-Cisplatin (GC) for squamous Non-Small Cell Lung Cancer (sqNSCLC). 2017, 102:72-72 Haematologica